newsfilter
← Latest News
GlobeNewswire·

Survey: Cardiovascular Patients on Aspirin Therapy Prefer VAZALORE® 81 mg

Results of National Patient Experience Survey Show 95% Satisfaction Rate with VAZALORE 81 mg as Aspirin Therapy Choice FDA-Approved VAZALORE Delivers Fast, Reliable Absorption of Aspirin SPARTA, N.J., Aug. 12, 2022 (GLOBE NEWSWIRE)